| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue: | $65K-51.9% | $135K-75.5% | $550K+44.0% | $382K |
| Cost of revenue | -$321K-161.0% | -$123K-339.3% | -$28K+65.4% | -$81K |
| Gross margin | -$256K-2233.3% | $12K-97.7% | $522K+73.4% | $301K |
| Research and development | $12.3M+11.6% | $11.0M-11.9% | $12.5M+24.8% | $10.0M |
| General and administrative | $7.8M+7.4% | $7.3M+2.7% | $7.1M+9.8% | $6.4M |
| Selling and marketing | $758K-28.0% | $1.1M-34.1% | $1.6M+18.6% | $1.3M |
| Total operating expenses | $20.9M+7.9% | $19.3M-8.7% | $21.2M+18.9% | $17.8M |
| Loss from operations | -$21.1M-9.2% | -$19.3M+6.5% | -$20.7M-18.0% | -$17.5M |
| Interest income | $931K+19.5% | $779K+7.7% | $723K+112.6% | $340K |
| Accretion income | $6K-96.6% | $178K-37.1% | $283K | $0 |
| Other income, net | $72K-1.4% | $73K-2.7% | $75K | — |
| Interest expense | -$60K+53.5% | -$129K+33.5% | -$194K+23.9% | -$255K |
| Total other income, net | $949K+5.3% | $901K+1.6% | $887K+943.5% | $85K |
| Net loss | -$20.2M-9.4% | -$18.4M+6.8% | -$19.8M-13.5% | -$17.4M |
| Net loss per common share, basic | -$0.65+4.4% | -$0.68+15.0% | -$0.80-6.7% | -$0.75 |
| Net loss per common share, diluted | -$0.65+4.4% | -$0.68+15.0% | -$0.80-6.7% | -$0.75 |
| Weighted average number of common shares outstanding, basic | 30.8M+13.3% | 27.2M+9.9% | 24.8M+6.9% | 23.2M |
| Weighted average number of common shares outstanding, diluted | 30.8M+13.3% | 27.2M+9.9% | 24.8M+6.9% | 23.2M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.